Choosing the right vasoactive agent for esophageal varices in cirrhosis patients;Quelle substance vaso-active choisir dans la rupture de varices oesophagiennes de la cirrhose?

Presse Medicale

Volumn 26, Issue 24, 1997, Pages 1146-1148

  De Parades, V ^a   Metreau, J M ^a   Patri, B ^a   Wdowik, A ^a  

^a Cabinet Medical   (France)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; SOMATOSTATIN; TERLIPRESSIN; VASOACTIVE AGENT;

COST BENEFIT ANALYSIS; DRUG CHOICE; DRUG EFFICACY; ESOPHAGUS VARICES; GOOD CLINICAL PRACTICE; HUMAN; LIVER CIRRHOSIS; PATIENT CARE; PORTAL HYPERTENSION; SHORT SURVEY;

ESOPHAGEAL AND GASTRIC VARICES; HORMONE ANTAGONISTS; HUMANS; LIVER CIRRHOSIS; RUPTURE, SPONTANEOUS; VASOCONSTRICTOR AGENTS;

EID: 0030760216     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (35)